Literature DB >> 33840832

Involving Students in the Distributed Pharmaceutical Analysis Laboratory: A Citizen-Science Project to Evaluate Global Medicine Quality.

Sarah L Bliese1, Margaret Berta1, Marya Lieberman1.   

Abstract

The distributed pharmaceutical analysis laboratory (DPAL) is a collaboration between 30 academic institutions around the world, whose goal is to determine the quality of medicines collected from partner organizations in low- and middle-income countries (LMICs). Institutions complete system suitability for a high-performance liquid chromatography (HPLC) system using United States Pharmacopeia (USP)-traceable reference standards, and are then approved to analyze batches of samples that are collected in LMICs by covert shoppers. Open Science Framework (OSF) allows DPAL participants access to resources for the program including an HPLC methodology manual, a wiki with HPLC troubleshooting information, detailed checklists and Excel templates for system suitability and sample assay, as well as steps for reporting results. Participants incorporate the DPAL program into their academic curriculum as undergraduate research or via lab activities for analytical chemistry or instrumental analysis courses. Over a thousand samples have been analyzed through DPAL in the last three years, and 168 samples with quality problems have been discovered, including falsified acetaminophen, adulterated amoxicillin-clavulanate and doxycycline, and substandard losartan. These quality problems are reported to the medicine regulatory agencies in the countries of origin and the WHO Rapid Alert System for further action. This real-world program gives students a hands-on opportunity to see the importance of analytical metrics taught in the classroom.

Entities:  

Keywords:  Analytical Chemistry; Applications of Chemistry; HPLC; Hands-On Learning; Inquiry-Based Learning; Instrumental Methods; Pharmaceuticals; Quantitative Analysis; Second-Year Undergraduate; Undergraduate Research

Year:  2020        PMID: 33840832      PMCID: PMC8026146          DOI: 10.1021/acs.jchemed.0c00904

Source DB:  PubMed          Journal:  J Chem Educ        ISSN: 0021-9584            Impact factor:   2.979


  3 in total

1.  Impact of poor-quality medicines in the 'developing' world.

Authors:  Paul N Newton; Michael D Green; Facundo M Fernández
Journal:  Trends Pharmacol Sci       Date:  2010-02-01       Impact factor: 14.819

2.  Paper analytical devices for fast field screening of beta lactam antibiotics and antituberculosis pharmaceuticals.

Authors:  Abigail A Weaver; Hannah Reiser; Toni Barstis; Michael Benvenuti; Debarati Ghosh; Michael Hunckler; Brittney Joy; Leah Koenig; Kellie Raddell; Marya Lieberman
Journal:  Anal Chem       Date:  2013-06-18       Impact factor: 6.986

3.  Prevalence and Estimated Economic Burden of Substandard and Falsified Medicines in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis.

Authors:  Sachiko Ozawa; Daniel R Evans; Sophia Bessias; Deson G Haynie; Tatenda T Yemeke; Sarah K Laing; James E Herrington
Journal:  JAMA Netw Open       Date:  2018-08-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.